F. Gomez

发表

Metaiodobenzylguanidine assessment of metastatic neuroblastoma: observer dependency and chemosensitivity evaluation. The SFOP Group.

D. Frappaz, V. Edeline, F. Giammarile, 2000, Medical and pediatric oncology.

Second malignant neoplasm following childhood cancer: A nested case-control study of a recent cohort (1987–2004) from the Childhood Cancer Registry of the Rhône-Alpes region in France

D. Frappaz, J. Stéphan, Y. Bertrand, 2016, Pediatric hematology and oncology.

Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.

J. Grill, P. Maingon, J. Habrand, 2003, International journal of radiation oncology, biology, physics.

The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary

I. Bodrogi, L. Geczi, F. Gomez, 2003, Journal of Cancer Research and Clinical Oncology.

Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie

A. Ravaud, J. Douillard, C. Lasset, 2005, World Journal of Urology.

[Interleukin-2 and interferon in metastatic kidney cancer. Experience of the French Immunotherapy Group].

J. Douillard, C. Lasset, C. Chevreau, 2002, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

Academic Difficulties and Occupational Outcomes of Adult Survivors of Childhood Leukemia Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation and Fractionated Total Body Irradiation Conditioning

D. Frappaz, C. Berger, C. Faure-Conter, 2014, Pediatric hematology and oncology.

Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie.

A. Ravaud, J. Douillard, B. Escudier, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase II Study with 5-Fluorouracil, Folinic Acid and Oxaliplatin (FOLFOX-4 Regimen) in Patients with Metastatic Renal Cell Carcinoma

J. Douillard, C. Linassier, C. Chevreau, 2002, Oncology.

Nonmetastatic pelvic Ewing sarcoma: report of the French society of pediatric oncology.

J. Habrand, O. Oberlin, C. Carrie, 1999, Medical and Pediatric Oncology.

Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil. Groupe Français d'Immunothérapie, Fédération Nationale des Centres de Lutte Contre le Cancer.

J. Rossi, J. Douillard, P. Viens, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil.

P. Viens, B. Escudier, T. Lesimple, 2002 .

Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP).

J. Habrand, F. Doz, J. Lagrange, 1999, International journal of radiation oncology, biology, physics.

Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie.

A. Ravaud, J. Douillard, B. Escudier, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial.

S. Culine, B. Bui, P. Biron, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Three-Year Results of the First Educational and Early Detection Program for Testicular Cancer in Hungary

I. Bodrogi, Z. Horváth, L. Geczi, 2001, Oncology.

Subcutaneous interleukin‐2 and interferon α in the treatment of patients with metastatic renal cell carcinoma—Less efficacy compared with intravenous interleukin‐2 and interferon α

A. Ravaud, J. Douillard, C. Chevreau, 2002 .

A phase 2 trial of whole‐brain radiotherapy combined with intravenous chemotherapy in patients with brain metastases from breast cancer

J. Blay, I. Ray-Coquard, L. Claude, 2008, Cancer.